To further confirm the in vivo relevance of CCR4 signaling on NI in the herein described TPAC model, we treated TPAC mice (aged 42 weeks) with the CCR4 inhibitor C021 3 times a week for 3 weeks and subsequently analyzed the severity of NI in the primary tumor via histology. Here, CCR4 is linked to neoplasm.